Uncategorized
Study follow-up completed for VisAbility micro-insert system
A 12-month follow-up on 360 patients in a phase 3 clinical trial of the VisAbility micro-insert system for presbyopia has been completed, Refocus Group announced in a press release.The company said it can now prepare a premarket approval submission to the FDA.